Candriam Equities L Biotech.I EUR Acc/ LU1120766032 /
| NAV2024-06-07 | Chg.+2.3501 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,249.3101EUR | +0.10% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | - | - | - | -11.00 | 9.00 | 8.02 | -2.36 | - |
| 2016 | -22.88 | -4.93 | -1.29 | 3.06 | 8.39 | -8.04 | 11.86 | -2.02 | 2.94 | -10.16 | 12.33 | -2.27 | -17.28% |
| 2017 | 2.99 | 8.66 | -0.73 | -0.63 | -6.06 | 7.75 | -0.77 | 5.59 | 1.39 | -4.99 | -2.01 | 0.83 | +11.43% |
| 2018 | 2.97 | -2.64 | -2.70 | -1.36 | 8.35 | 0.97 | 4.46 | 4.80 | -1.85 | -11.78 | 4.28 | -9.24 | -5.57% |
| 2019 | 12.84 | 4.24 | 0.92 | -4.67 | -4.18 | 7.07 | -0.09 | -1.27 | -3.22 | 7.98 | 13.15 | 0.65 | +36.28% |
| 2020 | -3.94 | -0.26 | -4.88 | 13.11 | 7.67 | 0.44 | -7.71 | -0.21 | 2.72 | -2.15 | 6.96 | 0.76 | +11.20% |
| 2021 | 2.61 | -2.43 | -1.06 | 0.36 | -3.34 | 9.33 | -1.38 | 4.46 | -2.39 | 0.38 | -1.61 | 1.44 | +5.86% |
| 2022 | -9.49 | -2.17 | 6.73 | -2.56 | -4.79 | 5.58 | 7.26 | 2.53 | 0.67 | 6.00 | 1.92 | -6.17 | +3.88% |
| 2023 | 1.21 | -3.40 | -1.97 | 0.66 | 2.31 | -1.05 | -1.18 | 1.42 | -1.89 | -5.97 | 2.68 | 12.11 | +3.96% |
| 2024 | 3.05 | 1.74 | 0.26 | -5.18 | 2.58 | 3.25 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 15.99% | 16.91% | 15.98% | 20.24% | 23.12% |
| Sharpe ratio | 0.61 | 1.35 | 0.34 | 0.14 | 0.30 |
| Best month | +12.11% | +12.11% | +12.11% | +12.11% | +13.15% |
| Worst month | -5.18% | -5.18% | -5.97% | -9.49% | -9.49% |
| Maximum loss | -9.49% | -9.49% | -13.26% | -20.59% | -26.96% |
| Outperformance | -3.12% | - | -0.76% | - | - |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,084.9900 | +10.25% | +7.65% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 222.8200 | +8.06% | +14.96% | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,086.2700 | +7.85% | +0.07% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,249.3101 | +9.12% | +20.98% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,439.8201 | +7.93% | +18.28% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 360.6900 | +7.87% | +21.97% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 328.9100 | +9.07% | +23.45% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 202.8400 | +5.22% | -1.69% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,865.0900 | +10.41% | +10.34% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 150.8700 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 606.0000 | +8.77% | +5.51% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,733.7700 | +10.31% | +7.82% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 199.3300 | +6.91% | -0.39% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 207.9400 | +7.83% | +2.08% | |
| Candriam Equities L Biotech.R US... | reinvestment | 271.6800 | +10.28% | +10.08% | |
| Candriam Equities L Biotechnolo... | reinvestment | 850.7800 | +9.17% | +6.84% | |
| Candriam Equities L Biotechnolog... | paying dividend | 777.0000 | +9.13% | +6.74% |
Performance
| YTD | +5.58% | ||
|---|---|---|---|
| 6 Months | +12.44% | ||
| 1 Year | +9.12% | ||
| 3 Years | +20.98% | ||
| 5 Years | +65.41% | ||
| 10 Years | - | ||
| Since start | +49.95% | ||
| Year | |||
| 2023 | +3.96% | ||
| 2022 | +3.88% | ||
| 2021 | +5.86% | ||
| 2020 | +11.20% | ||
| 2019 | +36.28% | ||
| 2018 | -5.57% | ||
| 2017 | +11.43% | ||
| 2016 | -17.28% | ||
